Related Experiment Videos

Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor

H Qian1, L Pipolo, W G Thomas

  • 1Molecular Endocrinology Laboratory, Baker Medical Research Institute, PO Box 6492, St. Kilda Road Central, Melbourne, Victoria 8008, Australia.

The Biochemical Journal
|October 21, 1999
PubMed

Insights

Protein kinase C (PKC) phosphorylates the type 1 angiotensin II receptor (AT(1A)) at multiple C-terminal sites. This study identifies three serine residues (Ser331, Ser338, Ser348) involved in PKC-mediated phosphorylation, revealing redundancy in receptor regulation.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Biochemistry

Background:

  • Protein kinase C (PKC) is known to phosphorylate the type 1 angiotensin II receptor (AT(1A)) C-terminus.
  • The specific phosphorylation sites and their contribution to AT(1A) receptor regulation remain unidentified.
  • Understanding these sites is crucial for elucidating angiotensin II signaling pathways.

Purpose of the Study:

  • To identify the specific serine residues in the AT(1A) receptor C-terminus phosphorylated by PKC.
  • To investigate the role of these phosphorylation sites in AT(1A) receptor regulation by angiotensin II (AngII) and PKC activators.
  • To determine the contribution of PKC phosphorylation to AT(1A) receptor function under varying agonist stimulation levels.

Main Methods:

  • Utilized epitope-tagged wild-type and mutant AT(1A) receptors (Ser to Ala substitutions at Ser(331), Ser(338), Ser(348)) expressed in Chinese hamster ovary K1 cells.
  • Stimulated receptors with AngII or phorbol ester (PMA) to activate PKC, and used a PKC inhibitor (bisindolylmaleimide).
  • Quantified receptor phosphorylation levels using Western blotting and compared phosphorylation in wild-type versus mutant receptors across different AngII concentrations.

Main Results:

  • AngII and PMA stimulation increased wild-type AT(1A) receptor phosphorylation, which was abolished by C-terminal truncation.
  • Single serine-to-alanine mutations reduced phosphorylation, but no single mutant completely inhibited AngII- or PMA-induced phosphorylation.
  • Triple mutation (Ser(331), Ser(338), Ser(348) to Ala) significantly reduced PMA- and AngII-induced phosphorylation, indicating redundancy and multiple PKC sites.
  • PKC contributed more to AT(1A) receptor phosphorylation at low AngII concentrations (1 nM), suggesting a role in initial receptor regulation.
  • No single PKC consensus site showed preferential utilization across different AngII concentrations.

Conclusions:

  • The AT(1A) receptor C-terminus contains at least three redundant PKC phosphorylation sites (Ser(331), Ser(338), Ser(348)).
  • PKC plays a significant role in agonist-stimulated AT(1A) receptor regulation, particularly at low AngII concentrations.
  • Multiple phosphorylation events at these sites may allow for independent or complementary regulatory functions of the AT(1A) receptor.

Related Concept Videos